Wordt geladen...
Minimal Residual Disease in Multiple Myeloma: State of the Art and Applications in Clinical Practice
Novel drugs have revolutionized multiple myeloma therapy in the last 20 years, with median survival that has doubled to up to 8–10 years. The introduction of therapeutic strategies, such as consolidation and maintenance after autologous stem cell transplants, has also ameliorated clinical results. T...
Bewaard in:
| Gepubliceerd in: | J Pers Med |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7565263/ https://ncbi.nlm.nih.gov/pubmed/32927719 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm10030120 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|